Mode
Text Size
Log in / Sign up
N/A N=141 Randomized Single-blind Prevention

Build Better Bones With Exercise

Osteoporotic Fractures · Spinal Fractures

Enrolled (actual)
141
Serious AEs
20.6%
Results posted
Nov 2019
Primary outcome: Primary: Feasibility of Recruitment and Retention — 66; 64 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Exercise and behaviour change strategies (Behavioral)
Age
Older Adult · 65+ yrs
Sex
Female
Sponsor
University of Waterloo
Primary completion
Dec 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility of Recruitment and Retention
66; 64
PRIMARY
Adherence
66
SECONDARY
Number of Fractures.
168; 163; 183; 178
SECONDARY
Number of Fallers
48; 36
SECONDARY
Occiput to Wall Distance
5.3; 6.2; 5.3; 6.1 0.811
SECONDARY
Scores on the Short Physical Performance Battery (SPPB)
9.6; 8.8; 9.7; 9.0 0.796
SECONDARY
Scores on Balance Outcome Measure for Elder Rehabilitation (BOOMER).
13.5; 13.2; 13.6; 13.2 0.719
SECONDARY
Quality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).
74.1; 75.7; 75.5; 75.7; 74.6; 75.7 0.854
SECONDARY
Scores on Exercise Self-efficacy Scales.
4.4; 4.4; 4.2; 4.0; 4.0; 4.0
SECONDARY
Score on Short-form Falls Efficacy Scale International (FES-I).
12.1; 12.9; 11.4; 11.5; 11.5; 12.3
SECONDARY
Productivity
1.89; 1.85; 1.60; 1.76; 1.32; 2.12 .951
SECONDARY
Physical Activity
6.7; 6.4; 43.2; 48.8; 168.8; 194.9 <0.05 sig
SECONDARY
Number of Serious Adverse Events.
18; 12
SECONDARY
Number of Individuals Screened and Eligible Per Collection Site.
141
SECONDARY
Number of Potentially Eligible Males
308
SECONDARY
Number of Participants With Multiple Falls
31; 22
SECONDARY
Total Number of Falls
130; 127
SECONDARY
Value of Direct Medical Resources Per Participant.
2127; 1823; 1680; 3130; 829; 848
SECONDARY
Value of Non-direct Medical Resources Per Participant.
5005; 4631; 998; 917; 1007; 872
SECONDARY
Participant Height
156.5; 156.1; 156.4; 155.9 0.536
SECONDARY
Activities of Daily Living
3.17; 3.46; 2.79; 2.75; 2.99; 3.05 .900
SECONDARY
Timed Loaded Standing Test
101.9; 107.5; 120; 106 .712
SECONDARY
Location of Vertebral Fractures
3; 1; 54; 42; 74; 88
SECONDARY
Participant Weight
65.1; 66.5; 66.1; 66.6 0.461

Summary

The long-term goal of our research team is to conduct a large multicentre study to evaluate whether tailored home exercise can prevent fractures in high-risk individuals. The proposed project will address the feasibility of such a trial, but will also evaluate the effect of exercise on quality of life, posture and many other outcomes important to individuals with vertebral fractures. Physiotherapists will conduct 6 home visits with participants to deliver the intervention (or social visit for controls) using a similar model to previous work by our team and others. The purpose of this pilot study is determining the feasibility of recruitment, retention and adherence of an international multicentre randomized controlled study evaluating the efficacy of thrice-weekly home exercise for one year among women with vertebral fracture. As secondary objectives, the investigators will examine the effects of exercise on function, balance, quality of life, pain, falls and fractures. The primary hypothesis is that the investigators will successfully recruit and retain the target sample, and achieve an adherence rate of 60%.

Eligibility Criteria

Inclusion Criteria

  • Has a) a known or suspected vertebral fracture of non-traumatic etiology OR b) one of the following:
  • documented height loss of ≥2cm
  • historical height loss of ≥6cm
  • visible hyperkyphosis
  • age greater than or equal to 65 years of age
  • able to understand instructions in english
  • able to give informed consent (no cognitive impairment)

Exclusion Criteria

  • Current or prior cancer
  • On dialysis, known liver, kidney or malabsorption disease
  • Progressive neurological disorder, unable to stand or walk for 10 metres, with/without gait aid or progressive disorder likely to prevent study completion, palliative care.
  • Current participation in muscle strengthening or similar exercise program ≥ 3 times per week
  • Uncontrolled hypertension or other contraindications to exercise
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01761084). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search